Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
93.52
+2.06 (2.25%)
At close: Mar 6, 2026, 4:00 PM EST
92.93
-0.59 (-0.63%)
After-hours: Mar 6, 2026, 5:46 PM EST
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $6.39 billion as of March 6, 2026. Its market cap has increased by 79.96% in one year.
Market Cap
6.39B
Enterprise Value
6.11B
1-Year Change
79.96%
Ranking
Category
Stock Price
$93.52
Market Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $6.39B, an increase of 684.62%. That is a compound annual growth rate of 27.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.39B | -10.60% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.82B |
| Arcellx | 6.69B |
| Belite Bio | 6.47B |
| Cogent Biosciences | 6.03B |
| Protagonist Therapeutics | 5.83B |
| CRISPR Therapeutics AG | 5.50B |
| Immunovant | 5.44B |
| Caris Life Sciences | 5.43B |